US 11773185
Anti-BACE1 antibodies and methods of use thereof
granted A61KA61K2039/505A61P
Quick answer
US patent 11773185 (Anti-BACE1 antibodies and methods of use thereof) held by DENALI THERAPEUTICS INC. expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- DENALI THERAPEUTICS INC.
- Grant date
- Tue Oct 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K2039/505, A61P, A61P25/16, A61P25/28